CMS and FDA announce ACCESS and TEMPO initiatives to expand technology-enabled care for Medicare beneficiaries with chronic conditions, focusing on outcomes-based payments and regulatory enforcement discretion.

FlyteHealth has been chosen by CMS to participate in the Medicare ACCESS Model, leveraging AI-driven virtual care to manage cardio-kidney-metabolic conditions and improve outcomes for older adults.

Manulife and Bupa announce a strategic collaboration in Hong Kong to enhance integrated healthcare solutions, combining insurance and personalized support for improved health outcomes.

CMS and FDA have initiated the ACCESS Model and TEMPO pilot to expand technology-driven care for Medicare chronic condition patients, focusing on outcomes-based payments and regulatory flexibility.

CMS finalizes 2026 Medicare OPPS and ASC payment rule introducing site-neutral payments, enhanced price transparency, and updated digital health policies to modernize outpatient care reimbursement.

CMS Innovation Center and FDA introduce ACCESS and TEMPO models to integrate digital health devices into Medicare, boosting care and payment innovation for chronic conditions.

HealthBridge platform proposes transforming African diaspora remittances into structured health insurance, addressing regulatory, operational, and coordination challenges to strengthen health financing and reduce out-of-pocket costs in Sub-Saharan Africa.

Explore AMA's advocacy on Medicare prior authorization reform, FDA's TEMPO pilot for digital health, CMS policy challenges, and proposed HIPAA cybersecurity updates impacting U.S. healthcare providers.

CMS and FDA introduce ACCESS and TEMPO models to enable digital health device integration in traditional Medicare, focusing on outcome-aligned payments, regulatory easing, and expanded patient access.

An overview of key issues in U.S. health insurance, FDA regulatory inconsistencies, health care costs, anti-vaccine impacts, and emerging digital health policies affecting public health.